Saturday, May 26, 2018

Makis Papataxiarchis

President, PhRMA Innovation Forum (PIF), Chairman, AMCHAM Pharma Committee

Makis Papataxiarchis
Makis Papataxiarchis

Makis Papataxiarchis has 20 years of experience in the Pharmaceutical sector and a 17-year old career at Johnson & Johnson. Since joining the company in 2000, he has held several senior roles such as Business Unit Director and Marketing & Sales Director.

In 2010 he moved to Romania as Janssen and Johnson & Johnson Managing Director. During his tenure in Romania was President of the National Association of Pharmaceutical Companies (ARPIM).

In 2013 he moved to the USA where he was appointed as National Director, Systems of Care, at Janssen Pharmaceuticals Inc. By the end of 2015, Mr. Papataxiarchis returns to his homeland as CEO of Janssen Pharmaceutical Companies of Johnson & Johnson for Greece, Cyprus and Malta. He is also President of PhRMA Innovation Forum (PIF) and Chairman of AMCHAM’s Pharma Committee.

He holds a Pharmacy degree, Master and PhD in Pharmaceuticals and Economics, as well as an MBA in Marketing Management.

International Speakers

Yuri Bender Yuri Bender is a financial journalist focusing on private banking, international asset management and capital markets. He has edited and launched a variety of titles at the Financial Times group and is currently Editor-in-Chief of the Professional Wealth Management pan-European and Asian magazine, website and events hub.
Patricia Vella Bonanno Patricia Vella Bonanno is an Advanced Pharmacist Practitioner at the Superintendence of Public Health at the Ministry for Health, Malta. The Superintendence is the Licensing Authority as designated by the Medicines Act and it is also responsible for regulation, of all Healthcare services, Environmental Health, Health Promotion and regulation of Healthcare Professionals.
Sara Burke Dr Sara Burke is a health policy analyst, working as a research fellow in the Centre for Health Policy and Management, in the School of Medicine, Trinity College Dublin. She co-ordinates an Irish Health Research Board funded project called 'Mapping the pathways to universal healthcare'.
Didier Duret Didier Duret joined in 1998, leading the Discretionary Portfolio Management Department, subsequently becoming Head of Financial Products and European Head of Product Development, before being appointed CIO. He held senior positions in investment management at UBS and Paribas, both in Switzerland.
Maurice Galla Maurice Galla is senior policy officer in the Directorate for Pharmaceuticals and Medical Technology at the Netherlands Ministry of Health, Welfare and Sports. His primary tasks involve EU cooperation in the field of pharmaceutical affairs and legislation.
Othon Iliopoulos Professor Othon Iliopoulos graduated from the National and Kapodistrian University of Athens Medical School. He completed a Residency and Chief Residency at the University of Wisconsin Medical School and a fellowship in Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School.
Gaetan Lafortune Gaétan Lafortune is a Senior Economist in the OECD Health Division. He is responsible for the development of the OECD health database, which provides a wide range of statistics on health and health systems across the 35 OECD member countries.
Yannis Natsis Yannis Natsis is a Board Member of the European Health Forum Gastein. He currently leads the advocacy for better and affordable medicines at the European Public Health Alliance (EPHA).
Dimitra Panteli Dimitra Panteli, M.D., M.Sc.P.H., Dr.P.H., is a 2016-17 German Harkness Fellow in Health Care Policy and Practice. She is currently a research fellow at the Department of Health Care Management at Berlin University of Technology, a role she has held for the past six years.
Dr. Rui Santos Ivo Dr. Rui Santos Ivo is President of the Central Administration of the Health System, IP (ACSS, I.P.), of the Ministry of Health. Since November 2011, he has been vice-president of ACSS, I.P. responsible for the areas of human resources, management of the health resources network, information systems in the health sector and the licensing of health units and monitoring of the use of medicines in hospitals, as well as the area of ​​the Conference Center Invoices.
  • ORGANIZED BY
  • IN COOPERATION WITH
PIF (Pharma Innovation Forum)
PIF (Pharma Innovation Forum)
  • GRAND SPONSOR
  • SPONSORS
  • SUPPORTERS
  • EXHIBITOR
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team